<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>75 patients with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> divided into five disease groups (previous <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo>, <z:hpo ids='HP_0001681'>angina pectoris</z:hpo>, <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo>, <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> obliterans) were studied and compared to 20 healthy subjects </plain></SENT>
<SENT sid="1" pm="."><plain>Antithrombin III (AT III) concentration was determined by single radial immunodiffusion; AT III and factor Xa-inhibitor (Xa-I) activities were measured by amidolytic methods </plain></SENT>
<SENT sid="2" pm="."><plain>No significant difference was found in any group of patients as compared to <z:mpath ids='MPATH_458'>normal</z:mpath> controls by <z:hpo ids='HP_0000001'>all</z:hpo> the methods </plain></SENT>
<SENT sid="3" pm="."><plain>A positive correlation was found between AT III concentration and AT III activity, AT III concentration and Xa-I activity, AT III activity and Xa-I activity </plain></SENT>
<SENT sid="4" pm="."><plain>Results are discussed in relation to the literature data </plain></SENT>
</text></document>